China’s Sinopharm reports strong interim results for its Covid-19 vaccine


900a0978-4a66-11eb-9c55-93e83087d811_image_hires_152540

HONG KONG, Jan 4 (SCMP): A vaccine developed by China National Pharmaceutical Group (Sinopharm) has been found to be 79.34 per cent effective against Covid-19, according to an interim analysis, the company said.

The vaccine was shown to be safe, and participants receiving the two-dose course produced a high level of antibodies against the virus at a rate of 99.52 per cent, according to a statement posted on Wednesday by the company’s subsidiary Beijing Institute of Biological Products – which has also formally submitted an application to China’s regulators for conditional listing, it said.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

SCMP , China , Covid-19 , Vaccine , Good Results

   

Next In Aseanplus News

Asean news headlines as at 9pm on Friday (May 3)
S'pore law firm Shook Lin & Bok hit by cyber attack; allegedly paid S$1.89mil in bitcoin as ransom
Vietnam introduces NVeID as only app to handle online administrative procedures
Three senior officers arrested for alleged extortion, says IGP
Singapore’s recall of popular spice mix prompts domestic food safety concerns in India
IGP: Chief editor of English portal to be questioned over 'Forest City casino' claim
HK actor Roger Kwok and former TVB star Cindy Au divorce after 18 years of marriage
Cambodia's Supreme Court upholds two-year prison sentence of casino strike leader
Thai PM takes swipe at central bank, as commercial banks reduce lending rates
Minister Airlangga Hartarto meets Asean sec-gen at Paris OECD meeting

Others Also Read